logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
E

Experimental Hematology & Oncology

IF13.5
论文数168
被引数
期刊论文 168
发表时间
delete
Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer
deleteExperimental Hematology & Oncology
IF13.5
delete2026-11-05
delete0
deleteOAAI
deleteMattia Marinucci; Federico Donà; Gina F. Boot; Cinzia Esposito; Elenia Toccafondi; Daniela Liberati; Andrej Benjak; Lara Zaidi; Melania Lazzari; Giulia Milardi; Karolina Guja-Jarosz; Miriam Cieri; Huiche Feng; Mairene Coto-Llerena; Raoul A. Droeser; Savas D. Soysal; Otto Kollmar; Guido Torzilli; Antonino Spinelli; Luigi M. Terracciano; Charlotte K. Y. Ng; Salvatore Piscuoglio
delete分享
delete收藏
SCGB3A2 marks a low-angiogenesis tumor cell state associated with extracellular PGK2 and angiostatin in lung adenocarcinomaSCGB3A2标记与肺腺癌中低血管生成肿瘤细胞状态相关的细胞外PGK2和血管抑素
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-30
delete0
deleteOAAI
deleteShu-Lin Zhao; Yu Cao; Yi-Zuo Shi; Min Zhang; Fu-qiang Dai; Tian-Hu Wang; Wei Liang; Hong Zhang
delete分享
delete收藏
HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translationHER2在实体瘤中：微环境特征及从机制到临床转化的多方面进展
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-28
delete0
deleteOAAI
deleteTianqi Zhang; Cong Tan; Hui Sun; Wenchao Gu; Wenfeng Wang; Midie Xu; Weiqi Sheng
delete分享
delete收藏
Glioblastoma as a dynamic tumor ecosystem: from molecular alterations to therapeutic translation胶质母细胞瘤作为一种动态肿瘤生态系统：从分子改变到治疗转化
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-28
delete0
deleteOAAI
deleteLukas Gorecki
delete分享
delete收藏
Timdarpacept (IMM01) combined with azacitidine (AZA) as first-line therapy in adults with higher risk chronic myelomonocytic leukemia (CMML): results from a prospective, multicenter, phase II studyTimdarpacept（IMM01）联合阿扎胞苷（AZA）作为高风险慢性粒单细胞白血病（CMML）成人患者的初始治疗：一项前瞻性、多中心、II期研究的结果
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-28
delete0
deleteOAAI
deleteLiya Ma; Wei Yang; Sujun Gao; Junmin Li; Qingsong Yin; Xingli Zhao; Xiaojing Yan; Sanfang Tu; Fei Li; Haiping Yang; Ronghua Hu; Shaoyuan Wang; Zheng Dong; Xiwen Zhao; Guodong Lu; Zhuli Wu; Wenzhi Tian; Hongyan Tong; Zhijian Xiao
delete分享
delete收藏
Correction: Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial更正：CD33靶向CAR-NK细胞疗法治疗复发/难治性AML的安全性与有效性：临床前评估和I期试验
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteRuihao Huang; Xiaoqi Wang; Hongju Yan; Xu Tan; Yingying Ma; Maihong Wang; Xiao Han; Jia Liu; Li Gao; Lei Gao; Guangjun Jing; Cheng Zhang; Qin Wen; Xi Zhang
delete分享
delete收藏
Blocking aryl hydrocarbon receptor remodels myeloid–T cell crosstalk and enhances anti-PD-1 response in the tumor microenvironment阻断芳烃受体重塑髓系细胞-T细胞串扰并增强肿瘤微环境中的抗PD-1反应
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteDong Kwon Kim; Sujeong Baek; Youngtaek Kim; Seung Min Yang; So Young Park; Su Jin Choi; Ju Hyeon Lee; Sang Hoon Lee; Jongho Cho; Daewon Cha; Dajeong Kim; Sunghwa Kim; Jae Hwan Kim; Byoung Chul Cho
delete分享
delete收藏
Correction: GPR109A controls neutrophil extracellular traps formation and improve early sepsis by regulating ROS/PAD4/Cit-H3 signal axis纠正：GPR109A通过调控ROS/PAD4/Cit-H3信号轴控制中性粒细胞胞外陷阱的形成并改善早期败血症
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteWenjin Guo; Qian Gong; Xiaofeng Zong; Dianjun Wu; Yuhang Li; Huijie Xiao; Jie Song; Sheng Zhang; Shoupeng Fu; Zhichun Feng; Lu Zhuang
delete分享
delete收藏
Comparative characterization of OncoPro™ and Wnt-based media reveals distinct phenotypic and pharmacologic states in patient-derived tumor organoids比较OncoPro™和Wnt-based培养基的特性揭示患者来源肿瘤类器官中不同的表型和药理学状态
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-26
delete0
deleteOAAI
deleteSofie Seghers; Maxim Le Compte; Felicia Rodrigues Fortes; Jana Baroen; Jasper Ott; Geert Roeyen; Vera Hartman; Samir Kumar-Singh; Lenny Coppens; Michiel de Maat; Niels Komen; Sylvie Van Den Broeck; Jody Valk; Wiebren Tjalma; Jeroen M. H. Hendriks; Paul Van Schil; Gilles Van Haesendonck; Sofia L. J. Peeters; Hans Prenen; Christophe Deben
delete分享
delete收藏
Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation实体瘤的适应性细胞疗法创新与新兴趋势：工程策略与临床转化
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-22
delete0
deleteOAAI
deletePeng Huang; WenLin Wu; Yu Min; Yi Zhang; YunFeng Tao; Zheran Liu; Zhigong Wei; Xingchen Peng
delete分享
delete收藏
Oncogenic RAS as an adaptive signaling ecosystem: context-dependent vulnerabilities and resistance-informed therapeutic design致癌RAS作为一个适应性信号生态系统：依赖背景的脆弱性及耐药性指导的疗法设计
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-22
delete0
deleteOAAI
deleteAmir Abbas Hamidi; Omeed Moaven; Reihaneh Alsadat Mahmoudian; Mohammad Reza Abbaszadegan
delete分享
delete收藏
Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinomaCobimetinib通过改变my-CAFs来抑制BRAFV600E突变型未分化甲状腺癌的肿瘤生存和免疫逃逸
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-20
delete0
deleteOAAI
deleteMario Udinotti; Niclas Ramm; Thamer Abed Alhaleem Amin Hamdan; Muhammad Sameer Ali Khan; Udo Siebolts; Marcus Bauer; Kerstin Lorenz; Christine Dierks; Claudia Wickenhauser; Barbara Seliger
delete分享
delete收藏
Venetoclax-based combinations in high-risk myelodysplastic syndromes: highlights from ASH 2025 & EHA 2026维奈克拉为基础的联合疗法在高风险骨髓增生异常综合征中的应用：ASH 2025与EHA 2026会议亮点
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-16
delete0
deleteOAAI
deleteInes Zugasti; Marina Cornejo; Sandra Castaño-Diez; Juan Jose Rodriguez-Sevilla; Albert Cortes-Bullich; Jordi Esteve; Marina Diaz-Beya
delete分享
delete收藏
Intratumoral microbiota in cancer immunotherapy: metabolic-epigenetic crosstalk and engineered bacterial therapeutics肿瘤内微生物群在癌症免疫治疗中的作用：代谢-表观遗传交叉对话与工程细菌疗法
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-16
delete0
deleteOAAI
deleteNiying Zhao; Huan Zhang; Yutong Pang; Lingqin Zhu; Qinghua Liu; Zhiya Zhang; Lin Shen; Yuqi He; Shuye Lin
delete分享
delete收藏
Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade肿瘤相关成纤维细胞中的代谢重编程：调控肿瘤免疫微环境及对免疫检查点抑制剂的应答
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-10
delete0
deleteOAAI
deleteLuoman Gan; Zhonglong Liu; Liren Cao; Xiaoyan Meng; Xuanhao Liu; Xu Wang; Yue He
delete分享
delete收藏
Beyond MYD88-only testing: MYD88/CD79B profiling improves molecular detection and MCD genotyping in VRL and CNS lymphomas超越仅MYD88检测：MYD88/CD79B分析提高了VRL和CNS淋巴瘤的分子检测和MCD基因分型
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-09
delete0
deleteOAAI
deleteMona M. Wang; Yuanhan Li; Gee Fung How; Candice E.H. Ho; Nagavalli DO Somasundaram; Jason Yongsheng Chan; Timothy Kwang Yong Tay; Than Hein; Anita Sook Yee Chan
delete分享
delete收藏
Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma靶向适应性EGFR反馈增强RMC-6236在胆管癌中的治疗效果
deleteExperimental Hematology & Oncology
IF13.5
delete2026-10-03
delete0
deleteOAAI
deleteShiori Yamazaki; Nao Hondo; Koya Yasukawa; Masato Kitazawa; Satoshi Nakamura; Yuta Yamamoto; Satoru Miyazaki; Hirokazu Tanaka; Masatsugu Kuroiwa; Naoki Ishizaka; Tadaaki Shimizu; Akira Shimizu; Yuji Soejima
delete分享
delete收藏
Next-generation CAR-T therapy for malignant brain tumors: latest updates from the 2026 AACR Annual Meeting下一代CAR-T疗法治疗恶性脑肿瘤：2026年AACR年会最新进展
deleteExperimental Hematology & Oncology
IF13.5
delete2026-09-28
delete0
deleteOAAI
deleteValbert Oliveira Costa Filho; Silvia Helena Barem Rabenhorst; Felipe Pantoja Mesquita
delete分享
delete收藏
Daraxonrasib and the era of pan-RAS inhibition: mechanisms, clinical advances, and resistance landscapes达拉卡龙拉西布与泛RAS抑制时代：机制、临床进展及耐药景观
deleteExperimental Hematology & Oncology
IF13.5
delete2026-09-28
delete0
deleteOAAI
deleteJiacheng Lou; Danlu Zhang
delete分享
delete收藏
Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT成人AML完全缓解伴可测量微小残留病患者间基因半相合、同胞全相合及无关供者allo-HCT的比较：EBMT全球委员会和ALWP的研究
deleteExperimental Hematology & Oncology
IF13.5
delete2026-09-19
delete0
deleteOAAI
deleteYishan Ye; Jacques-Emmanuel Galimard; Myriam Labopin; Francis Ayuk; Ibrahim Yakoub-Agha; Matthias Stelljes; Urpu Salmenniemi; Thomas Schroeder; Gesine Bug; Maria-Pilar Gallego-Hernanz; Edouard Forcade; Jakob Passweg; Maija Itala-Remes; Simona Piemontese; Jaime Sanz; Ali Bazarbachi; Arnon Nagler; Eolia Brissot; Lin Li; Yi Luo; Jimin Shi; Yanmin Zhao; Mohamad Mohty; He Huang; Fabio Ciceri; Norbert Claude Gorin
delete分享
delete收藏